CORC

浏览/检索结果: 共1条,第1-1条 帮助

限定条件        
已选(0)清除 条数/页:   排序方式:
Phase III study of trastuzumab emtansine (T-DM1) vs trastuzumab as adjuvant therapy in patients with HER2-positive early breast cancer with residual invasive disease after neoadjuvant chemotherapy and HER2-targeted therapy including trastuzumab: Primary results from KATHERINE 会议论文
作者:  Geyer, C. E., Jr.;  Huang, C-S;  Mano, M. S.;  Loibl, S.;  Mamounas, E. P.
收藏  |  浏览/下载:27/0  |  提交时间:2019/12/05


©版权所有 ©2017 CSpace - Powered by CSpace